MPD: Phenotype measures mapped to VT:0008246, leukocyte morphology trait

Phenotype measures associated with ontology term
VT:0008246 'leukocyte morphology trait'

All measures in this list are mapped to the ontology descendants of VT:0008246. None are mapped to VT:0008246 directly.

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year

Benoist1:1	Benoist1	immune cell quantification	(none)	percentage of thymic CD4 Treg cells that are CD25^hi [%] Treg_thy_CD25 25801	inbred	33	m	5-6wks	N=3	2007

Benoist1:2	Benoist1	immune cell quantification	(none)	percentage of thymic CD4 Treg cells that are Foxp3+ [%] Treg_thy_Foxp3 25802	inbred	10	m	5-6wks	N=3	2007

Benoist1:3	Benoist1	immune cell quantification	(none)	percentage of splenic CD4 Treg cells that are CD25^hi [%] Treg_spl_CD25 25803	inbred	31	m	5-6wks	N=3	2007

Benoist1:4	Benoist1	immune cell quantification	(none)	percentage of splenic CD4 Treg cells that are Foxp3+ [%] Treg_spl_Foxp3 25804	inbred	10	m	5-6wks	N=3	2007

CGDpheno1:1	CGDpheno1	complete blood count	(none)	white blood cell count (WBC; per volume x 10³) [n/µL] WBC 31801	inbred w/CC8	72	both	11wks	N=7	2009

CGDpheno1:5	CGDpheno1	complete blood count	(none)	neutrophil differential (NEUT; percentage of total WBC) [%] pctNEUT 31805	inbred w/CC8	72	both	11wks	N=7	2009

CGDpheno1:6	CGDpheno1	complete blood count	(none)	lymphocyte differential (LYM; percentage of total WBC) [%] pctLYMP 31806	inbred w/CC8	72	both	11wks	N=7	2009

CGDpheno1:7	CGDpheno1	complete blood count	(none)	monocyte differential (MONO; percentage of total WBC) [%] pctMONO 31807	inbred w/CC8	72	both	11wks	N=7	2009

CGDpheno1:8	CGDpheno1	complete blood count	(none)	eosinophil differential (EOS; percentage of total WBC) [%] pctEOS 31808	inbred w/CC8	72	both	11wks	N=7	2009

CGDpheno3:6	CGDpheno3	complete blood count	(none)	white blood cell count (WBC; per volume x 10³) [n/µL] WBC 43906	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:7	CGDpheno3	complete blood count	(none)	lymphocyte differential (LYM; percentage of total WBC) [%] pctLYMP 43907	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:8	CGDpheno3	complete blood count	(none)	neutrophil differential (NEUT; percentage of total WBC) [%] pctNEUT 43908	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:9	CGDpheno3	complete blood count	(none)	monocyte differential (MONO; percentage of total WBC) [%] pctMONO 43909	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:10	CGDpheno3	complete blood count	(none)	basophil differential (BASO; percentage of total WBC) [%] pctBASO 43910	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:11	CGDpheno3	complete blood count	(none)	eosinophil differential (EOS; percentage of total WBC) [%] pctEOS 43911	CC diallel w/par	62	both	7wks	N=5	2012

CGDpheno3:12	CGDpheno3	complete blood count	(none)	large unstained cells (LUC; percentage of total WBC) [%] pctLUC 43912	CC diallel w/par	62	both	7wks	N=5	2012

Chen1:1	Chen1	immune cell quantification	(none)	percentage of total TCRβ+ cells that are invariant NK T cells, peripheral blood [%] pct_iNKT_T_pb 52301	inbred	38	m	8-10wks	N=4	2011

Chen1:2	Chen1	immune cell quantification	(none)	percentage of invariant NK T cells that express CD4, peripheral blood [%] pct_iNKT_CD4_pb 52302	inbred	34	m	8-10wks	N=4	2011

Chen1:3	Chen1	immune cell quantification	(none)	percentage of total TCRβ+ cells that are invariant NK T cells, spleen [%] pct_iNKT_T_spleen 52303	inbred	38	m	8-10wks	N=4	2011

Chen1:4	Chen1	immune cell quantification	(none)	percentage of invariant NK T cells that express CD4, spleen [%] pct_iNKT_CD4_spleen 52304	inbred	35	m	8-10wks	N=4	2011

Chen1:5	Chen1	immune cell quantification	(none)	peripheral blood to spleen ratio of invariant NK T cells [ratio] iNKT_pb_spl_ratio 52305	inbred	38	m	8-10wks	N=4	2011

Chen1:6	Chen1	immune cell quantification	(none)	percentage of total TCRβ^hi cells that are invariant NK T cells, thymus [%] pct_iNKT_T_thymus 52306	inbred	38	m	8-10wks	N=4	2011

Chen1:7	Chen1	immune cell quantification	(none)	percentage of invariant NK T cells that express CD4, thymus [%] pct_iNKT_CD4_thymus 52307	inbred	35	m	8-10wks	N=4	2011

Chen1:8	Chen1	immune cell quantification	(none)	peripheral blood to thymus ratio of invariant NK T cells [ratio] iNKT_pb_thy_ratio 52308	inbred	38	m	8-10wks	N=4	2011

Chesler2:11	Chesler2	complete blood count	(none)	white blood cell count (WBC; units per volume x 10³) [n/µL] WBC 43413	CC diallel w/par	48	both	7-15wks	N=2	2011

Chesler2:12	Chesler2	complete blood count	(none)	lymphocyte count (LYM; units per volume x 10³) [n/µL] LYM 43414	CC diallel w/par	48	both	7-15wks	N=2	2011

Chesler2:13	Chesler2	complete blood count	(none)	lymphocyte differential (LYM; percentage of viable WBC) [%] pct_LYM 43415	CC diallel w/par	48	both	7-15wks	N=2	2011

Chesler2:14	Chesler2	complete blood count	(none)	monocyte count (MONO; units per volume x 10³) [n/µL] MONO 43416	CC diallel w/par	48	both	7-15wks	N=2	2011

Chesler2:15	Chesler2	complete blood count	(none)	monocyte differential (MONO; percentage of viable WBC) [%] pct_MONO 43417	CC diallel w/par	48	both	7-15wks	N=2	2011

Chesler2:16	Chesler2	complete blood count	(none)	granulocyte count (GRA; units per volume x 10³) [n/µL] GRA 43418	CC diallel w/par	48	both	7-15wks	N=2	2011

Chesler2:17	Chesler2	complete blood count	(none)	granulocyte differential (GRA; percentage of total viable WBC) [%] pct_GRA 43419	CC diallel w/par	48	both	7-15wks	N=2	2011

Chesler2:18	Chesler2	complete blood count	(none)	eosinophil differential (EOS; percentage of viable WBC) [%] pct_EOS 43420	CC diallel w/par	48	both	7-15wks	N=2	2011

Chesler3:13	Chesler3	complete blood count	(none)	white blood cell count (WBC; units per volume x 10³) [n/µL] WBC 43513	CC pre w/par	199	both	7-15wks	N=1	2011

Chesler3:14	Chesler3	complete blood count	(none)	lymphocyte count (LYM; units per volume x 10³) [n/µL] LYM 43514	CC pre w/par	198	both	7-15wks	N=1	2011

Chesler3:15	Chesler3	complete blood count	(none)	lymphocyte differential (LYM; percentage of viable WBC) [%] pct_LYM 43515	CC pre w/par	198	both	7-15wks	N=1	2011

Chesler3:16	Chesler3	complete blood count	(none)	monocyte count (MONO; units per volume x 10³) [n/µL] MONO 43516	CC pre w/par	198	both	7-15wks	N=1	2011

Chesler3:17	Chesler3	complete blood count	(none)	monocyte differential (MONO; percentage of viable WBC) [%] pct_MONO 43517	CC pre w/par	198	both	7-15wks	N=1	2011

Chesler3:18	Chesler3	complete blood count	(none)	granulocyte count (GRA; units per volume x 10³) [n/µL] GRA 43518	CC pre w/par	198	both	7-15wks	N=1	2011

Chesler3:19	Chesler3	complete blood count	(none)	granulocyte differential (GRA; percentage of total viable WBC) [%] pct_GRA 43519	CC pre w/par	198	both	7-15wks	N=1	2011

Chesler3:20	Chesler3	complete blood count	(none)	eosinophil differential (EOS; percentage of viable WBC) [%] pct_EOS 43520	CC pre w/par	198	both	7-15wks	N=1	2011

Collins1:2	Collins1	complete blood count	(none)	white blood cell count (WBC; per volume x 10³) [n/µL] WBC 45102	CC pre w/par	138	m	10-14wks	N=1	2012

Collins1:3	Collins1	complete blood count	(none)	lymphocyte count (LYM; per volume x 10³) [n/µL] LYM 45103	CC pre w/par	138	m	10-14wks	N=1	2012

Collins1:4	Collins1	complete blood count	(none)	lymphocyte differential (LYM; percentage of total WBC) [%] LYM_pct 45104	CC pre w/par	138	m	10-14wks	N=1	2012

Collins1:5	Collins1	complete blood count	(none)	neutrophil count (NEUT; per volume x 10³) [n/µL] NEUT 45105	CC pre w/par	138	m	10-14wks	N=1	2012

Collins1:6	Collins1	complete blood count	(none)	neutrophil differential (NEUT; percentage of total WBC) [%] NEUT_pct 45106	CC pre w/par	138	m	10-14wks	N=1	2012

Collins1:7	Collins1	complete blood count	(none)	monocyte count (MONO; per volume x 10³) [n/µL] MONO 45107	CC pre w/par	138	m	10-14wks	N=1	2012

Collins1:8	Collins1	complete blood count	(none)	monocyte differential (MONO; percentage of total WBC) [%] MONO_pct 45108	CC pre w/par	138	m	10-14wks	N=1	2012

Collins1:9	Collins1	complete blood count	(none)	eosinophil count (EOS; per volume x 10³) [n/µL] EOS 45109	CC pre w/par	138	m	10-14wks	N=1	2012

Collins1:10	Collins1	complete blood count	(none)	eosinophil differential (EOS; percentage of total WBC) [%] EOS_pct 45110	CC pre w/par	138	m	10-14wks	N=1	2012

Collins1:11	Collins1	complete blood count	(none)	basophil count (BASO; per volume x 10³) [n/µL] BASO 45111	CC pre w/par	138	m	10-14wks	N=1	2012

Collins1:12	Collins1	complete blood count	(none)	basophil differential (BASO; percentage of total WBC) [%] BASO_pct 45112	CC pre w/par	138	m	10-14wks	N=1	2012

Donahue5:1	Donahue5	immune cell quantification	(none)	neutrophil differential (percentage of viable WBC) [%] pct_NEUT 41401	B6.A consomic w/par	22	both	7wks	N=8	2011

Donahue5:2	Donahue5	immune cell quantification	(none)	eosinophil differential (percentage of viable WBC) [%] pct_EOS 41402	B6.A consomic w/par	22	both	7wks	N=8	2011

Donahue5:3	Donahue5	immune cell quantification	(none)	monocyte differential (percentage of viable WBC) [%] pct_MONO 41403	B6.A consomic w/par	22	both	7wks	N=8	2011

Donahue5:4	Donahue5	immune cell quantification	(none)	inflammatory monocytes (percentage of viable WBC) [%] pct_MONO_inflam 41404	B6.A consomic w/par	22	both	7wks	N=8	2011

Donahue5:5	Donahue5	immune cell quantification	(none)	resident monocytes (percentage of viable WBC) [%] pct_MONO_resident 41405	B6.A consomic w/par	22	both	7wks	N=8	2011

Donahue5:6	Donahue5	immune cell quantification	(none)	B cells (percentage of viable WBC) [%] pct_B_cells 41406	B6.A consomic w/par	22	both	7wks	N=8	2011

Donahue5:7	Donahue5	immune cell quantification	(none)	natural killer (NK) cells (percentage of viable WBC) [%] pct_NK_cells 41407	B6.A consomic w/par	22	both	7wks	N=8	2011

Donahue5:8	Donahue5	immune cell quantification	(none)	mature natural killer (NK) cells (percentage of viable WBC) [%] pct_NK_mature 41408	B6.A consomic w/par	22	both	7wks	N=8	2011

Donahue5:9	Donahue5	immune cell quantification	(none)	T cells (percentage of viable WBC) [%] pct_T_cells 41409	B6.A consomic w/par	22	both	7wks	N=8	2011

Donahue5:10	Donahue5	immune cell quantification	(none)	CD4 T cells (percentage of viable WBC) [%] pct_CD4 41410	B6.A consomic w/par	22	both	7wks	N=8	2011

Donahue5:12	Donahue5	immune cell quantification	(none)	CD8 T cells (percentage of viable WBC) [%] pct_CD8 41412	B6.A consomic w/par	22	both	7wks	N=8	2011

Donahue6:1	Donahue6	immune cell quantification	(none)	neutrophil differential (percentage of viable WBC) [%] pct_NEUT 41501	B6.PWD consomic w/par	28	both	7wks	N=8	2011

Donahue6:2	Donahue6	immune cell quantification	(none)	eosinophil differential (percentage of viable WBC) [%] pct_EOS 41502	B6.PWD consomic w/par	28	both	7wks	N=8	2011

Donahue6:3	Donahue6	immune cell quantification	(none)	monocyte differential (percentage of viable WBC) [%] pct_MONO 41503	B6.PWD consomic w/par	28	both	7wks	N=8	2011

Donahue6:4	Donahue6	immune cell quantification	(none)	inflammatory monocytes (percentage of viable WBC) [%] pct_MONO_inflam 41504	B6.PWD consomic w/par	28	both	7wks	N=8	2011

Donahue6:5	Donahue6	immune cell quantification	(none)	resident monocytes (percentage of viable WBC) [%] pct_MONO_resident 41505	B6.PWD consomic w/par	28	both	7wks	N=8	2011

Donahue6:6	Donahue6	immune cell quantification	(none)	B cells (percentage of viable WBC) [%] pct_B_cells 41506	B6.PWD consomic w/par	28	both	7wks	N=8	2011

Donahue6:7	Donahue6	immune cell quantification	(none)	natural killer (NK) cells (percentage of viable WBC) [%] pct_NK_cells 41507	B6.PWD consomic w/par	28	both	7wks	N=8	2011

Donahue6:8	Donahue6	immune cell quantification	(none)	mature natural killer (NK) cells (percentage of viable WBC) [%] pct_NK_mature 41508	B6.PWD consomic w/par	28	both	7wks	N=8	2011

Donahue6:9	Donahue6	immune cell quantification	(none)	T cells (percentage of viable WBC) [%] pct_T_cells 41509	B6.PWD consomic w/par	28	both	7wks	N=8	2011

Donahue6:10	Donahue6	immune cell quantification	(none)	CD4 T cells (percentage of viable WBC) [%] pct_CD4 41510	B6.PWD consomic w/par	28	both	7wks	N=8	2011

Donahue6:11	Donahue6	immune cell quantification	(none)	CD8 T cells (percentage of viable WBC) [%] pct_CD8 41511	B6.PWD consomic w/par	28	both	7wks	N=8	2011

Eumorphia1:16	Eumorphia1	complete blood count	(none)	white blood cell count (WBC; per volume x 10³) [n/µL] WBC 23916	inbred	6	both	12wks	N=23	2007

Eumorphia1:26	Eumorphia1	complete blood count	(none)	lymphocyte count (LYMP; units per volume x 10³) [n/µL] LYMP 23926	inbred	4	both	12wks	N=15	2007

Eumorphia1:27	Eumorphia1	complete blood count	(none)	monocyte count (MONO; units per volume x 10³) [n/µL] MONO 23927	inbred	4	both	12wks	N=15	2007

Farmer1:34	Farmer1	immune cell quantification	(none)	percentage of viable CD4⁺ T cells in 150 µl collected blood [%] CD4 11334	QTL population		both	6wks	N=206	2001

Farmer1:35	Farmer1	immune cell quantification	(none)	percentage of viable CD8⁺ T cells in 150 µl collected blood [%] CD8 11335	QTL population		both	6wks	N=206	2001

Farmer1:36	Farmer1	immune cell quantification	(none)	percentage of viable B220⁺ B cells in 150 µl collected blood [%] B220 11336	QTL population		both	6wks	N=206	2001

Farmer1:37	Farmer1	immune cell quantification	(none)	percentage of viable IgM⁺ B cells in 150 µl collected blood [%] lgM 11337	QTL population		both	6wks	N=206	2001

Farmer1:38	Farmer1	immune cell quantification	(none)	percentage of macrophages in 150 µl collected blood [%] Macrophages 11338	QTL population		both	6wks	N=206	2001

Farmer1:39	Farmer1	immune cell quantification	(none)	percentage of viable granulocytes in 150 µl collected blood [%] Granulocytes 11339	QTL population		both	6wks	N=206	2001

Gatti2:1	Gatti2	complete blood count	(none)	white blood cell counts [thousands/µL] WBC 28901	DO population		both	10-12wks	N=371	2014

Gatti2:2	Gatti2	complete blood count	(none)	neutrophil counts [n/µL] NEUR 28902	DO population		both	10-12wks	N=371	2014

GMC15:1	GMC15	complete blood count	(none)	white blood cell count (WBC; per volume x 10³) [n/µL] WBC 56401	inbred w/CC8	8	both	20-21wks	N=11	2018

Graham1:29	Graham1	immune cell quantification	West Nile virus	percentage of CD3+ T cells that are CD4+ in brain, post infection [%] CD4_brain 63329 day 7 day 12 day 21 day 28	CC RIX	5	m	8-10wks	N=3	2015

Graham1:33	Graham1	immune cell quantification	West Nile virus	percentage of CD3+ T cells that are CD4+ in spleen, post infection [%] CD4_spleen 63333 day 7 day 12 day 21 day 28	CC RIX	2	m	8-10wks	N=3	2015

Graham1:37	Graham1	immune cell quantification	West Nile virus	percentage of CD4+ T cells that are Foxp3+ in the brain, post infection [%] Treg_brain 63337 day 7 day 12 day 21 day 28	CC RIX	5	m	8-10wks	N=3	2015

Graham1:41	Graham1	immune cell quantification	West Nile virus	percentage of CD4+ T cells that are Foxp3+ in the spleen, post infection [%] Treg_spleen 63341 day 7 day 12 day 21 day 28	CC RIX	2	m	8-10wks	N=3	2015

Graham1:45	Graham1	immune cell quantification	West Nile virus	percentage of CD3+ T cells that are CD8+ in brain, post infection [%] CD8_brain 63345 day 7 day 12 day 21 day 28	CC RIX	5	m	8-10wks	N=3	2015

Graham1:49	Graham1	immune cell quantification	West Nile virus	percentage of CD3+ T cells that are CD8+ in spleen, post infection [%] CD8_spleen 63349 day 7 day 12 day 21 day 28	CC RIX	2	m	8-10wks	N=3	2015

Graham1:53	Graham1	immune cell quantification	West Nile virus	percentage of CD3+ T cells that are NS4b+ in brain, post infection [%] NS4b_brain 63353 day 7 day 12 day 21 day 28	CC RIX	5	m	8-10wks	N=3	2015

Graham1:57	Graham1	immune cell quantification	West Nile virus	percentage of CD3+ T cells that are NS4b+ in spleen, post infection [%] NS4b_spleen 63357 day 7 day 12 day 21 day 28	CC RIX	2	m	8-10wks	N=3	2015

Graham3:9	Graham3	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD4+ T cells [%] CD4_pos_tot 113800	CC RIX	102	m	8-10wks	N=4	2021

Graham3:10	Graham3	immune cell quantification	(none)	percentage of splenic CD4+ T cells that are Foxp3+ (Treg) [%] Tregs 113801	CC RIX	102	m	8-10wks	N=4	2021

Graham3:11	Graham3	immune cell quantification	(none)	percentage of splenic Treg cells that are CD29+ [%] Treg_CD29_pos 113802	CC RIX	102	m	8-10wks	N=4	2021

Graham3:12	Graham3	immune cell quantification	(none)	percentage of splenic Treg cells that are CD44hi [%] Treg_CD44_hi 113803	CC RIX	102	m	8-10wks	N=4	2021

Graham3:13	Graham3	immune cell quantification	(none)	percentage of splenic Treg cells that are CD73+ [%] Treg_CD73_pos 113804	CC RIX	102	m	8-10wks	N=4	2021

Graham3:14	Graham3	immune cell quantification	(none)	percentage of splenic Treg cells that are CTLA-4+ [%] Treg_CTLA4_pos 113805	CC RIX	102	m	8-10wks	N=4	2021

Graham3:15	Graham3	immune cell quantification	(none)	percentage of splenic Treg cells that are CXCR3+ [%] Treg_CXCR3_pos 113806	CC RIX	102	m	8-10wks	N=4	2021

Graham3:16	Graham3	immune cell quantification	(none)	percentage of splenic Treg cells that are ICOS+ (inducible costimulator) [%] Treg_ICOS_pos 113807	CC RIX	102	m	8-10wks	N=4	2021

Graham3:21	Graham3	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD3+ T cells (memory precursor panel) [%] mp_CD3_pos 113812	CC RIX	92	m	8-10wks	N=4	2021

Graham3:22	Graham3	immune cell quantification	(none)	percentage of splenic CD3+ T cells that are CD8+ (memory precursor panel) [%] mp_CD3_pos_CD8_pos 113813	CC RIX	92	m	8-10wks	N=4	2021

Graham3:23	Graham3	immune cell quantification	(none)	percentage of splenic CD8+ T cells that are CD44+ (memory precursor panel) [%] mp_CD8_pos_CD44_pos 113814	CC RIX	91	m	8-10wks	N=4	2021

Graham3:24	Graham3	immune cell quantification	(none)	percentage of splenic CD8+ T cells that are CD62L- (memory precursor panel) [%] mp_CD8_pos_CD62L_neg 113815	CC RIX	76	m	8-10wks	N=3	2021

Graham3:25	Graham3	immune cell quantification	(none)	percentage of splenic CD8+ T cells that are Ki67+ (memory precursor panel) [%] mp_CD8_pos_Ki67_pos 113816	CC RIX	92	m	8-10wks	N=4	2021

Graham3:26	Graham3	immune cell quantification	(none)	percentage of splenic CD3+ T cells that are CD4+ (memory precursor panel) [%] mp_CD3_pos_CD4_pos 113817	CC RIX	92	m	8-10wks	N=4	2021

Graham3:27	Graham3	immune cell quantification	(none)	percentage of splenic CD4+ T cells that are CD44+ (memory precursor panel) [%] mp_CD4_pos_CD44_pos 113818	CC RIX	91	m	8-10wks	N=4	2021

Graham3:28	Graham3	immune cell quantification	(none)	percentage of splenic CD4+ T cells that are CD62L- (memory precursor panel) [%] mp_CD4_pos_CD62L_neg 113819	CC RIX	73	m	8-10wks	N=3	2021

Graham3:29	Graham3	immune cell quantification	(none)	percentage of splenic CD4+ T cells that are Ki67+ (memory precursor panel) [%] mp_CD4_pos_Ki67_pos 113820	CC RIX	92	m	8-10wks	N=4	2021

Graham3:34	Graham3	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD3+ T cells (memory panel) [%] mem_CD3_pos 113825	CC RIX	68	m	8-10wks	N=3	2021

Graham3:35	Graham3	immune cell quantification	(none)	percentage of splenic CD3+ T cells that are CD8+ (memory panel) [%] mem_CD3_pos_CD8_pos 113826	CC RIX	68	m	8-10wks	N=3	2021

Graham3:36	Graham3	immune cell quantification	(none)	percentage of splenic CD8+ T cells that are CD44+ (memory panel) [%] mem_CD8_pos_CD44_pos 113827	CC RIX	73	m	8-10wks	N=3	2021

Graham3:37	Graham3	immune cell quantification	(none)	percentage of splenic CD8+ T cells that are CD62L- (memory panel) [%] mem_CD8_pos_CD62L_neg 113828	CC RIX	68	m	8-10wks	N=3	2021

Graham3:38	Graham3	immune cell quantification	(none)	percentage of splenic CD8+ T cells that are Ki67+ (memory panel) [%] mem_CD8_pos_Ki67_pos 113829	CC RIX	73	m	8-10wks	N=3	2021

Graham3:39	Graham3	immune cell quantification	(none)	percentage of splenic CD3+ T cells that are CD4+ (memory panel) [%] mem_CD3_pos_CD4_pos 113830	CC RIX	68	m	8-10wks	N=3	2021

Graham3:40	Graham3	immune cell quantification	(none)	percentage of splenic CD4+ T cells that are CD44+ (memory panel) [%] mem_CD4_pos_CD44_pos 113831	CC RIX	73	m	8-10wks	N=3	2021

Graham3:41	Graham3	immune cell quantification	(none)	percentage of splenic CD4+ T cells that are CD62L- (memory panel) [%] mem_CD4_pos_CD62L_neg 113832	CC RIX	68	m	8-10wks	N=3	2021

Graham3:42	Graham3	immune cell quantification	(none)	percentage of splenic CD4+ T cells that are Ki67+ (memory panel) [%] mem_CD4_pos_Ki67_pos 113833	CC RIX	73	m	8-10wks	N=3	2021

Graham3:47	Graham3	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD3+ T cells following stimulation with anti-CD3 and anti CD28 [%] ics_CD3_pos 113838	CC RIX	102	m	8-10wks	N=4	2021

Graham3:48	Graham3	immune cell quantification	(none)	percentage of splenic CD3+ T cells that are CD8+ following stimulation with anti-CD3 and anti-CD28 [%] ics_CD3_pos_CD8_pos 113839	CC RIX	102	m	8-10wks	N=4	2021

Graham3:49	Graham3	immune cell quantification	(none)	percentage of splenic CD8+ T cells that are IL-17+ by intracellular cytokine staining following stimulation with anti-CD3 and anti-CD28 [%] ics_CD8_pos_IL17_pos 113840	CC RIX	102	m	8-10wks	N=4	2021

Graham3:50	Graham3	immune cell quantification	(none)	percentage of splenic CD8+ T cells that are IFNg+ by intracellular cytokine staining following stimulation with anti-CD3 and anti-CD28 [%] ics_CD8_pos_IGNg_pos 113841	CC RIX	102	m	8-10wks	N=4	2021

Graham3:51	Graham3	immune cell quantification	(none)	percentage of splenic CD3+ T cells that are CD4+ following stimulation with anti-CD3 and anti-CD28 [%] ics_CD3_pos_CD4_pos 113842	CC RIX	102	m	8-10wks	N=4	2021

Graham3:52	Graham3	immune cell quantification	(none)	percentage of splenic CD4+ T cells that are IL-17+ by intracellular cytokine staining following stimulation with anti-CD3 and anti-CD28 [%] ics_CD4_pos_IL17_pos 113843	CC RIX	102	m	8-10wks	N=4	2021

Graham3:53	Graham3	immune cell quantification	(none)	percentage of splenic CD4+ T cells that are IFNg+ by intracellular cytokine staining following stimulation with anti-CD3 and anti-CD28 [%] ics_CD4_pos_IFNg_pos 113844	CC RIX	102	m	8-10wks	N=4	2021

Graham3:54	Graham3	immune cell quantification	(none)	percentage of splenic CD4+ T cells that are Tbet+ (transcription factor) by intracellular staining following stimulation with anti-CD3 and anti-CD28 [%] ics_CD4_pos_Tbet_pos 113845	CC RIX	92	m	8-10wks	N=4	2021

Graubert1:1	Graubert1	complete blood count	(none)	white blood cell count (WBC; per volume x 10³) [n/µL] WBC 11601	inbred	20	both	9wks	N=12	2006

Graubert1:2	Graubert1	complete blood count	(none)	neutrophil count (NEUT; units per volume x 10³) [n/µL] NEUT 11602	inbred	20	both	9wks	N=12	2006

Graubert1:3	Graubert1	complete blood count	(none)	lymphocyte count (LYMP; units per volume x 10³) [n/µL] LYMP 11603	inbred	20	both	9wks	N=12	2006

Graubert1:4	Graubert1	complete blood count	(none)	neutrophil differential (NEUT; percentage of total WBC) [%] pct_NEUT 11604	inbred	20	both	9wks	N=12	2006

Graubert1:5	Graubert1	complete blood count	(none)	lymphocyte differential (LYM; percentage of total WBC) [%] pct_LYMP 11605	inbred	20	both	9wks	N=12	2006

Hackstein1:1	Hackstein1	immune cell quantification	(none)	bronchoalveolar lavage total leukocyte count (x 10³) [n] BAL 49101	inbred	5	m	7-11wks	N=5	2012

Hackstein1:2	Hackstein1	immune cell quantification	(none)	bronchoalveolar lavage macrophages (percentage of leukocytes) [%] BAL_MAC 49102	inbred	5	m	7-11wks	N=5	2012

Hackstein1:3	Hackstein1	immune cell quantification	(none)	bronchoalveolar lavage dendritic cells (percentage of CD45+ cells) [%] DC 49103	inbred	5	m	7-11wks	N=9	2012

Hackstein1:4	Hackstein1	immune cell quantification	(none)	bronchoalveolar lavage plasmacytoid dendritic cells (percentage of CD45+ cells) [%] DC_plasmacytoid 49104	inbred	5	m	7-11wks	N=9	2012

Hackstein1:5	Hackstein1	immune cell quantification	(none)	bronchoalveolar lavage monocytic dendritic cells (percentage of CD45+ cells) [%] DC_monocytic 49105	inbred	5	m	7-11wks	N=9	2012

Hackstein1:6	Hackstein1	immune cell quantification	(none)	bronchoalveolar lavage CD103+ dendritic cells (percentage of CD45+ cells) [%] DC_103 49106	inbred	5	m	7-11wks	N=9	2012

Hackstein1:7	Hackstein1	immune cell quantification	(none)	bronchoalveolar lavage CD11b^hi MHC^hi dendritic cells (percentage of CD45+ cells) [%] DC_11b 49107	inbred	5	m	7-11wks	N=9	2012

Hackstein1:8	Hackstein1	immune cell quantification	(none)	bronchoalveolar lavage Siglec F+ F4/80+ macrophages (percentage of CD45+ cells) [%] MAC 49108	inbred	5	m	7-11wks	N=9	2012

Hackstein1:9	Hackstein1	immune cell quantification	(none)	bronchoalveolar lavage neutrophils (percentage of CD45+ cells) [%] NEUT 49109	inbred	5	m	7-11wks	N=9	2012

Hackstein1:10	Hackstein1	immune cell quantification	(none)	bronchoalveolar lavage eosinophils (percentage of CD45+ cells) [%] EOS 49110	inbred	5	m	7-11wks	N=9	2012

Hackstein1:11	Hackstein1	immune cell quantification	(none)	bronchoalveolar lavage Lin^neg CD90+ innate cells (percentage of CD45+ cells) [%] Lin_neg_90_plus 49111	inbred	5	m	7-11wks	N=6	2012

Hackstein1:12	Hackstein1	immune cell quantification	(none)	bronchoalveolar lavage Lin^neg CD90^- innate cells (percentage of CD45+ cells) [%] Lin_neg_90_neg 49112	inbred	5	m	7-11wks	N=6	2012

Hackstein1:13	Hackstein1	immune cell quantification	(none)	bronchoalveolar lavage CD19+ B cells (percentage of CD45+ cells) [%] B_cells 49113	inbred	5	m	7-11wks	N=8	2012

Hackstein1:14	Hackstein1	immune cell quantification	(none)	bronchoalveolar lavage CD3+ T cells (percentage of CD45+ cells) [%] T_CD3 49114	inbred	5	m	7-11wks	N=9	2012

Hackstein1:15	Hackstein1	immune cell quantification	(none)	bronchoalveolar lavage CD3+ CD8+ T cells (percentage of CD45+ cells) [%] T_CD8 49115	inbred	5	m	7-11wks	N=9	2012

Hackstein1:16	Hackstein1	immune cell quantification	(none)	bronchoalveolar lavage CD3+ CD4+ T cells (percentage of CD45+ cells) [%] T_CD4 49116	inbred	5	m	7-11wks	N=9	2012

Hackstein1:17	Hackstein1	immune cell quantification	(none)	bronchoalveolar lavage CD3+ CD4+ CD25+ T cells (percentage of CD45+ cells) [%] T_CD4_25 49117	inbred	5	m	7-11wks	N=8	2012

Hackstein1:18	Hackstein1	immune cell quantification	(none)	bronchoalveolar lavage CD3+ CD4+ CD25^hi Treg cells (percentage of CD45+ cells) [%] T_CD4_25hi 49118	inbred	5	m	7-11wks	N=5	2012

Hackstein1:19	Hackstein1	immune cell quantification	(none)	bronchoalveolar lavage CD3+ CD4+ CD25^hi Foxp3+ Treg cells (percentage of CD45+ cells) [%] T_CD4_foxp3 49119	inbred	5	m	7-11wks	N=5	2012

Hackstein1:20	Hackstein1	immune cell quantification	(none)	bronchoalveolar lavage CD3+ CD4+ CD25^hi Foxp3+ CD39+ Treg cells (percentage of CD45+ cells) [%] T_CD4_39 49120	inbred	5	m	7-11wks	N=5	2012

Hackstein1:21	Hackstein1	immune cell quantification	(none)	bronchoalveolar lavage CD3+ gamma-delta T cells (percentage of CD45+ cells) [%] T_gd 49121	inbred	5	m	7-11wks	N=9	2012

Hackstein1:22	Hackstein1	immune cell quantification	(none)	bronchoalveolar lavage CD49+ natural killer (NK) cells (percentage of CD45+ cells) [%] NK 49122	inbred	5	m	7-11wks	N=9	2012

Haston1:3	Haston1	bronchoalveolar lavage assessment	radiation	percentage of macrophages in bronchoalveolar lavage [%] BAL_mac 48803	inbred	26	both	15-36wks	N=6	2012

Haston1:4	Haston1	bronchoalveolar lavage assessment	radiation	percentage of lymphocytes in bronchoalveolar lavage [%] BAL_lym 48804	inbred	26	both	15-36wks	N=6	2012

Haston1:5	Haston1	bronchoalveolar lavage assessment	radiation	percentage of neutrophils in bronchoalveolar lavage [%] BAL_neut 48805	inbred	26	both	15-36wks	N=6	2012

Haston1:6	Haston1	histopathology	radiation	average number of mast cells per mm² of lung tissue [n] mast_cells 48806	inbred	25	both	15-36wks	N=6	2012

Hillebrands1:1	Hillebrands1	histopathology	(none)	number of perivascular immune cell clusters per renal cross-section [n] clusternum 51101	inbred	23	both	90wks	N=7	2014

Hillebrands1:2	Hillebrands1	histopathology	(none)	relative size of perivascular immune cell clusters [%] clustersize 51102	inbred	20	both	90wks	N=7	2014

HMDPpheno5:1	HMDPpheno5	complete blood count	(none)	white blood cell count (WBC; units per volume x 10³) [n/µL] WBC 48901	HMDP w/par	79	m	16wks	N=3	2013

HMDPpheno5:7	HMDPpheno5	complete blood count	(none)	lymphocyte count (LYM; units per volume x 10³) [n/µL] LYM 48907	HMDP w/par	79	m	16wks	N=3	2013

HMDPpheno5:13	HMDPpheno5	complete blood count	(none)	lymphocyte differential (LYM; percentage of viable WBC) [%] pct_LYM 48913	HMDP w/par	79	m	16wks	N=3	2013

HMDPpheno5:19	HMDPpheno5	complete blood count	(none)	monocyte count (MONO; units per volume x 10³) [n/µL] MONO 48919	HMDP w/par	79	m	16wks	N=3	2013

HMDPpheno5:25	HMDPpheno5	complete blood count	(none)	monocyte differential (MONO; percentage of viable WBC) [%] pct_MONO 48925	HMDP w/par	79	m	16wks	N=3	2013

HMDPpheno5:31	HMDPpheno5	complete blood count	(none)	granulocyte count (GRA; units per volume x 10³) [n/µL] GRA 48931	HMDP w/par	79	m	16wks	N=3	2013

HMDPpheno5:37	HMDPpheno5	complete blood count	(none)	granulocyte differential (GRA; percentage of total viable WBC) [%] pct_GRA 48937	HMDP w/par	79	m	16wks	N=3	2013

JaxCC1:9209	JaxCC1	complete blood count	(none)	white blood cell count (WBC; units per volume x 10³) [n/µL] WBC 89209	CC	18	both	17-19wks	N=6	2017

JaxCC1:9210	JaxCC1	complete blood count	(none)	basophil differential (percent of total WBC) [%] pct_BASO 89210	CC	18	both	17-19wks	N=6	2017

JaxCC1:9211	JaxCC1	complete blood count	(none)	eosinophil differential (percent of total WBC) [%] pct_EOS 89211	CC	18	both	17-19wks	N=6	2017

JaxCC1:9212	JaxCC1	complete blood count	(none)	lymphocyte differential (percent of total WBC) [%] pct_LYM 89212	CC	18	both	17-19wks	N=6	2017

JaxCC1:9213	JaxCC1	complete blood count	(none)	monocyte differential (percent of total WBC) [%] pct_MONO 89213	CC	18	both	17-19wks	N=6	2017

JaxCC1:9214	JaxCC1	complete blood count	(none)	neutrophil differential (percent of total WBC) [%] pct_NEUT 89214	CC	18	both	17-19wks	N=6	2017

JaxCC1:9215	JaxCC1	complete blood count	(none)	large unstained cells (percent of total WBC) [%] pct_LUC 89215	CC	18	both	17-19wks	N=6	2017

JaxKOMP-EAP:423	JaxKOMP-EAP	complete blood count	(none)	white blood cell count (WBC; units per volume x 10³) [n/µL] WBC white_blood_cells_wbc 100281	KOMP	1833	both	18wks	N=7	2021

JaxKOMP-EAP:435	JaxKOMP-EAP	complete blood count	(none)	neutrophil differential (percent of total WBC) [%] pct_NEUT neutrophils_neut 100293	KOMP	1833	both	18wks	N=7	2021

JaxKOMP-EAP:436	JaxKOMP-EAP	complete blood count	(none)	lymphocyte differential (percent of total WBC) [%] pct_LYM lymphocytes_lym 100294	KOMP	1833	both	18wks	N=7	2021

JaxKOMP-EAP:437	JaxKOMP-EAP	complete blood count	(none)	monocyte differential (percent of total WBC) [%] pct_MONO monocytes_mono 100295	KOMP	1833	both	18wks	N=7	2021

JaxKOMP-EAP:438	JaxKOMP-EAP	complete blood count	(none)	eosinophil differential (percent of total WBC) [%] pct_EOS eosinophils_eos 100296	KOMP	1832	both	18wks	N=7	2021

JaxKOMP-EAP:439	JaxKOMP-EAP	complete blood count	(none)	large unstained cells (percent of total WBC) [%] pct_LUC pct_large_unstained_cells_luc 100297	KOMP	1442	both	18wks	N=7	2021

JaxKOMP-EAP:440	JaxKOMP-EAP	complete blood count	(none)	basophil differential (percent of total WBC) [%] pct_BASO basophils_baso 100298	KOMP	1825	both	18wks	N=7	2021

JaxKOMP-LAP:311	JaxKOMP-LAP	complete blood count	(none)	white blood cell count (WBC; units per volume x 10³) [n/µL] WBC white_blood_cells_wbc 101281	KOMP	100	both	75-81wks	N=6	2021

JaxKOMP-LAP:323	JaxKOMP-LAP	complete blood count	(none)	neutrophil differential (percent of total WBC) [%] pct_NEUT neutrophils_neut 101293	KOMP	100	both	75-81wks	N=6	2021

JaxKOMP-LAP:324	JaxKOMP-LAP	complete blood count	(none)	lymphocyte differential (percent of total WBC) [%] pct_LYM lymphocytes_lym 101294	KOMP	100	both	75-81wks	N=6	2021

JaxKOMP-LAP:325	JaxKOMP-LAP	complete blood count	(none)	monocyte differential (percent of total WBC) [%] pct_MONO monocytes_mono 101295	KOMP	102	both	75-81wks	N=6	2021

JaxKOMP-LAP:326	JaxKOMP-LAP	complete blood count	(none)	eosinophil differential (percent of total WBC) [%] pct_EOS eosinophils_eos 101296	KOMP	101	both	75-81wks	N=6	2021

JaxKOMP-LAP:327	JaxKOMP-LAP	complete blood count	(none)	large unstained cells (percent of total WBC) [%] pct_LUC pct_large_unstained_cells_luc 101297	KOMP	62	both	75-81wks	N=6	2021

JaxKOMP-LAP:328	JaxKOMP-LAP	complete blood count	(none)	basophil differential (percent of total WBC) [%] pct_BASO basophils_baso 101298	KOMP	99	both	75-81wks	N=6	2021

Jaxpheno4:1	Jaxpheno4	complete blood count	(none)	white blood cell count (WBC; per volume x 10³) [n/µL] WBC 22901 age 8wks age 16wks	inbred	11	both		N=17	2006

Jaxpheno4:10	Jaxpheno4	complete blood count	(none)	neutrophil count (NEUT; units per volume x 10³) [n/µL] NEUT 22910 age 8wks age 16wks	inbred	11	both		N=17	2006

Jaxpheno4:12	Jaxpheno4	complete blood count	(none)	lymphocyte count (LYM; units per volume x 10³) [n/µL] LYMPH 22912 age 8wks age 16wks	inbred	11	both		N=17	2006

Jaxpheno4:14	Jaxpheno4	complete blood count	(none)	monocyte count (MONO; units per volume x 10³) [n/µL] MONO 22914 age 8wks age 16wks	inbred	11	both		N=17	2006

Jaxpheno4:16	Jaxpheno4	complete blood count	(none)	eosinophil count (EOS; units per volume x 10³) [n/µL] EOS 22916 age 8wks age 16wks	inbred	11	both		N=17	2006

Jaxpheno4:18	Jaxpheno4	complete blood count	(none)	basophil count (BASO; units per volume x 10³) [n/µL] BASO 22918 age 8wks age 16wks	inbred	11	both		N=17	2006

Jaxpheno4:30	Jaxpheno4	complete blood count	(none)	neutrophil differential (NEUT; percentage of total WBC) [%] pct_NEUT 22930 age 8wks age 16wks	inbred	11	both		N=17	2006

Jaxpheno4:32	Jaxpheno4	complete blood count	(none)	lymphocyte differential (LYM; percentage of total WBC) [%] pct_LYMPH 22932 age 8wks age 16wks	inbred	11	both		N=17	2006

Jaxpheno4:34	Jaxpheno4	complete blood count	(none)	monocyte differential (MONO; percentage of total WBC) [%] pct_MONO 22934 age 8wks age 16wks	inbred	11	both		N=17	2006

Jaxpheno4:36	Jaxpheno4	complete blood count	(none)	eosinophil differential (EOS; percentage of total WBC) [%] pct_EOS 22936 age 8wks age 16wks	inbred	11	both		N=17	2006

Jaxpheno4:38	Jaxpheno4	complete blood count	(none)	basophil differential (BASO; percentage of total WBC) [%] pct_BASO 22938 age 8wks age 16wks	inbred	11	both		N=17	2006

Jaxpheno6:1	Jaxpheno6	immune cell quantification	(none)	splenic CD4 T cells (percentage of total viable cells) [%] pct_CD4 23101 8wks 16wks	inbred	11	both		N=9	2006

Jaxpheno6:3	Jaxpheno6	immune cell quantification	(none)	splenic CD8 T cells (percentage of total viable cells) [%] pct_CD8 23103 8wks 16wks	inbred	11	both		N=9	2006

Jaxpheno6:5	Jaxpheno6	immune cell quantification	(none)	splenic NK T cells (percentage of total viable cells) [%] pct_NKT 23105 8wks 16wks	inbred	11	both		N=9	2006

Jaxpheno6:7	Jaxpheno6	immune cell quantification	(none)	splenic NK cells (percentage of total viable cells) [%] pct_NK 23107 8wks 16wks	inbred	11	both		N=9	2006

Jaxpheno6:9	Jaxpheno6	immune cell quantification	(none)	splenic B cells (percentage of total viable cells) [%] pct_B 23109 8wks 16wks	inbred	11	both		N=9	2006

Jaxpheno6:20	Jaxpheno6	immune cell quantification	(none)	splenic granulocytes (percentage of total viable cells) [%] pct_Granu 23120 8wks 16wks	inbred	11	both		N=9	2006

Jaxpheno6:22	Jaxpheno6	immune cell quantification	(none)	splenic monocytes (percentage of total viable cells) [%] pct_Mono 23122 8wks 16wks	inbred	11	both		N=9	2006

Justice2:4	Justice2	complete blood count	(none)	white blood cell count (WBC; per volume x 10³) [n/µL] WBC 13204	inbred	16	both	12-16wks	N=12	2002

Justice2:14	Justice2	complete blood count	(none)	neutrophil differential (NEUT; percentage of total WBC) [%] pctN 13214	inbred	16	both	12-16wks	N=12	2002

Justice2:15	Justice2	complete blood count	(none)	lymphocyte differential (LYM; percentage of total WBC) [%] pctL 13215	inbred	16	both	12-16wks	N=12	2002

Justice2:16	Justice2	complete blood count	(none)	monocyte differential (MONO; percentage of total WBC) [%] pctM 13216	inbred	16	both	12-16wks	N=12	2002

Justice2:17	Justice2	complete blood count	(none)	eosinophil differential (EOS; percentage of total WBC) [%] pctE 13217	inbred	16	both	12-16wks	N=12	2002

Justice2:18	Justice2	complete blood count	(none)	basophil differential (BASO; percentage of total WBC) [%] pctB 13218	inbred	16	both	12-16wks	N=12	2002

Lake1:1	Lake1	complete blood count	(none)	white blood cell count (WBC; per volume x 10³) [n/µL] WBC 19901	B6.A consomic w/par	23	both	7wks	N=8	2005

Lake1:3	Lake1	complete blood count	(none)	neutrophil differential (NEUT; percentage of total WBC) [%] pct_NEUT 19903	B6.A consomic w/par	23	both	7wks	N=8	2005

Lake1:4	Lake1	complete blood count	(none)	lymphocyte differential (LYM; percentage of total WBC) [%] pct_LYM 19904	B6.A consomic w/par	23	both	7wks	N=8	2005

Lake1:5	Lake1	complete blood count	(none)	monocyte differential (MONO; percentage of total WBC) [%] pct_MONO 19905	B6.A consomic w/par	23	both	7wks	N=8	2005

Lake1:6	Lake1	complete blood count	(none)	eosinophil differential (EOS; percentage of total WBC) [%] pct_EOS 19906	B6.A consomic w/par	23	both	7wks	N=8	2005

Lake1:7	Lake1	complete blood count	(none)	large unstained cell differential (LUC; percentage of total WBC) [%] pct_LUC 19907	B6.A consomic w/par	23	both	7wks	N=8	2005

Lake1:8	Lake1	complete blood count	(none)	basophil differential (BASO; percentage of total WBC) [%] pct_BASO 19908	B6.A consomic w/par	23	both	7wks	N=8	2005

Lake1:80	Lake1	complete blood count	(none)	neutrophil count (NEUT; units per volume x 10³) [n/µL] NEUT 19980	B6.A consomic w/par	23	both	7wks	N=8	2005

Lake1:81	Lake1	complete blood count	(none)	lymphocyte count (LYMP; units per volume x 10³) [n/µL] LYM 19981	B6.A consomic w/par	23	both	7wks	N=8	2005

Lake1:82	Lake1	complete blood count	(none)	monocyte count (MONO; units per volume x 10³) [n/µL] MONO 19982	B6.A consomic w/par	23	both	7wks	N=8	2005

Lake1:83	Lake1	complete blood count	(none)	eosinophil count (EOS; units per volume x 10³) [n/µL] EOS 19983	B6.A consomic w/par	23	both	7wks	N=8	2005

Lake1:84	Lake1	complete blood count	(none)	large unstained cells count (LUC; units per volume x 10³) [n/µL] LUC 19984	B6.A consomic w/par	23	both	7wks	N=8	2005

Lake1:85	Lake1	complete blood count	(none)	basophil count (BASO; units per volume x 10³) [n/µL] BASO 19985	B6.A consomic w/par	23	both	7wks	N=8	2005

Lesage1:1	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD3- [%] CD3_neg 63501	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:2	Lesage1	immune cell quantification	(none)	percentage of splenic CD3- lymphocytes that are NK cells (CD49+ CD19-) [%] NK_cells_of_CD3_neg 63502	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:3	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are NK cells (CD49+ CD19-) [%] NK_cells_of_tot 63503	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:4	Lesage1	immune cell quantification	(none)	percentage of splenic NK cells that are CD27- CD11b- [%] CD27_neg_CD11b_neg 63504	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:5	Lesage1	immune cell quantification	(none)	percentage of splenic NK cells that are CD27+ CD11b- [%] CD27_pos_CD11b_neg 63505	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:6	Lesage1	immune cell quantification	(none)	percentage of splenic NK cells that are CD27+ CD11b+ [%] CD27_pos_CD11b_pos 63506	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:7	Lesage1	immune cell quantification	(none)	percentage of splenic NK cells that are CD27- CD11b+ [%] CD27_neg_CD11b_pos 63507	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:8	Lesage1	immune cell quantification	(none)	percentage of splenic NK cells that are pre-mNK (B220+ CD11c+) [%] pre_mNK_of_NK 63508	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:9	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are pre-mNK (B220+ CD11c+) [%] pre_mNK_of_tot 63509	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:10	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are NK T cells (TCRb+ CD1d+) [%] NKT_cells 63510	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:11	Lesage1	immune cell quantification	(none)	percentage of splenic NK T cells that are CD4+ CD8- [%] CD4_pos_CD8_neg_of_NKT 63511	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:12	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD4+ NK T cells [%] CD4_pos_CD8_neg_NKT_of_tot 63512	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:13	Lesage1	immune cell quantification	(none)	percentage of splenic NK T cells that are CD4- CD8- [%] CD4_neg_CD8_neg_of_NKT 63513	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:14	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD4- CD8- NK T cells [%] CD4_neg_CD8_neg_NKT_of_tot 63514	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:15	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are T cells [%] T_cells 63515	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:16	Lesage1	immune cell quantification	(none)	percentage of splenic T cells that are CD4+ CD8- [%] CD4_pos_CD8_neg_of_Tcells 63516	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:17	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD4+ T cells [%] CD4_pos_CD8_neg_of_tot 63517	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:18	Lesage1	immune cell quantification	(none)	percentage of splenic T cells that are CD4- CD8+ [%] CD4_neg_CD8_pos_of_Tcells 63518	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:19	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD8+ T cells [%] CD4_neg_CD8_pos_of_tot 63519	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:20	Lesage1	immune cell quantification	(none)	percentage of splenic T cells that are CD4- CD8- [%] CD4_neg_CD8_neg_of_Tcells 63520	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:21	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD4- CD8- T cells [%] CD4_neg_CD8_neg_of_tot 63521	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:22	Lesage1	immune cell quantification	(none)	ratio of splenic CD4+ to CD8+ T cells [ratio] CD4_CD8_ratio 63522	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:23	Lesage1	immune cell quantification	(none)	percentage of splenic leukocytes that are plasmacytoid dendritic cells [%] pDC 63523	CC w/par	74	both	5-8wks	N=2	2018

Lesage1:24	Lesage1	immune cell quantification	(none)	percentage of splenic leukocytes that are conventional dendritic cells [%] cDC 63524	CC w/par	74	both	5-8wks	N=2	2018

Lesage1:25	Lesage1	immune cell quantification	(none)	percentage of splenic conventional dendritic cells that are merocytic [%] mDC_of_cDC 63525	CC w/par	74	both	5-8wks	N=2	2018

Lesage1:26	Lesage1	immune cell quantification	(none)	percentage of splenic leukocytes that are merocytic dendritic cells [%] mDC_of_tot 63526	CC w/par	74	both	5-8wks	N=2	2018

Lesage1:27	Lesage1	immune cell quantification	(none)	percentage of splenic conventional dendritic cells that are cDC1 [%] cDC1_of_cDC 63527	CC w/par	74	both	5-8wks	N=2	2018

Lesage1:28	Lesage1	immune cell quantification	(none)	percentage of splenic leukocytes that are cDC1 conventional dendritic cells [%] cDC1_of_tot 63528	CC w/par	74	both	5-8wks	N=2	2018

Lesage1:29	Lesage1	immune cell quantification	(none)	percentage of splenic conventional dendritic cells that are cDC2 [%] cDC2_of_cDC 63529	CC w/par	74	both	5-8wks	N=2	2018

Lesage1:30	Lesage1	immune cell quantification	(none)	percentage of splenic leukocytes that are cDC2 conventional dendritic cells [%] cDC2_of_tot 63530	CC w/par	74	both	5-8wks	N=2	2018

Lesage2:9	Lesage2	immune cell quantification	(none)	total number of splenic lymphocytes (x 10⁶) [n] spleen_cells_tot 131924	CC w/par	76	both	5-8wks	N=2	2024

Lesage2:10	Lesage2	immune cell quantification	(none)	number of B cells in spleen (x 10⁶) [n] B_cells_tot 131925	CC w/par	76	both	5-8wks	N=2	2024

Lesage2:11	Lesage2	immune cell quantification	(none)	percentage of splenic lymphocytes that are B cells (CD3-CD49b-B220+CD19+) [%] B_cells_pct 131926	CC w/par	76	both	5-8wks	N=2	2024

Peters1:1	Peters1	complete blood count	(none)	white blood cell count (WBC; per volume x 10³) [n/µL] WBC 6201	inbred w/CC7	43	both	10wks	N=12	2001

Peters1:11	Peters1	complete blood count	(none)	neutrophil differential (percent of total WBC) [%] NEUT 6211	inbred w/CC7	43	both	10wks	N=12	2001

Peters1:12	Peters1	complete blood count	(none)	lymphocyte differential (percent of total WBC) [%] LYM 6212	inbred w/CC7	43	both	10wks	N=12	2001

Peters1:13	Peters1	complete blood count	(none)	monocyte differential (percent of total WBC) [%] MONO 6213	inbred w/CC7	43	both	10wks	N=11	2001

Peters1:14	Peters1	complete blood count	(none)	eosinophil differential (percent of total WBC) [%] EOS 6214	inbred w/CC7	43	both	10wks	N=11	2001

Peters1:15	Peters1	complete blood count	(none)	large unstained cell differential (percent of total WBC) [%] LUC 6215	inbred w/CC7	43	both	10wks	N=12	2001

Peters1:16	Peters1	complete blood count	(none)	basophil differential (percent of total WBC) [%] BASO 6216	inbred w/CC7	43	both	10wks	N=11	2001

Peters2:1	Peters2	complete blood count	(none)	white blood cell count (WBC; per volume x 10³) [n/µL] WBC 6501	AXB BXA	28	both	11wks	N=8	2004

Peters2:11	Peters2	complete blood count	(none)	neutrophil differential (percent of total WBC) [%] NEUT 6511	AXB BXA	28	both	11wks	N=8	2004

Peters2:12	Peters2	complete blood count	(none)	lymphocyte differential (percent of total WBC) [%] LYM 6512	AXB BXA	28	both	11wks	N=8	2004

Peters2:13	Peters2	complete blood count	(none)	monocyte differential (percent of total WBC) [%] MONO 6513	AXB BXA	28	both	11wks	N=8	2004

Peters2:14	Peters2	complete blood count	(none)	eosinophil differential (percent of total WBC) [%] EOS 6514	AXB BXA	28	both	11wks	N=8	2004

Peters2:15	Peters2	complete blood count	(none)	large unstained cell differential (percent of total WBC) [%] LUC 6515	AXB BXA	28	both	11wks	N=8	2004

Peters2:16	Peters2	complete blood count	(none)	basophil differential (percent of total WBC) [%] BASO 6516	AXB BXA	28	both	11wks	N=8	2004

Peters4:1	Peters4	complete blood count	(none)	white blood cell count (WBC; per volume x 10³) [n/µL] WBC 24301 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:9	Peters4	complete blood count	(none)	neutrophil count (NEUT; units per volume x 10³) [n/µL] NEUT 24309 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:13	Peters4	complete blood count	(none)	lymphocyte count (LYM; units per volume x 10³) [n/µL] LYMPH 24313 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:17	Peters4	complete blood count	(none)	monocyte count (MONO; units per volume x 10³) [n/µL] MONO 24317 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:21	Peters4	complete blood count	(none)	eosinophil count (EOS; units per volume x 10³) [n/µL] EOS 24321 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:25	Peters4	complete blood count	(none)	basophil count (BASO; units per volume x 10³) [n/µL] BASO 24325 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:29	Peters4	complete blood count	(none)	large unstained cells count (LUC; units per volume x 10³) [n/µL] LUC 24329 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:33	Peters4	complete blood count	(none)	neutrophil differential (NEUT; percentage of total WBC) [%] pctNEUT 24333 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:37	Peters4	complete blood count	(none)	lymphocyte differential (LYM; percentage of total WBC) [%] pctLYMPH 24337 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:41	Peters4	complete blood count	(none)	monocyte differential (MONO; percentage of total WBC) [%] pctMONO 24341 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:45	Peters4	complete blood count	(none)	eosinophil differential (EOS; percentage of total WBC) [%] pctEOS 24345 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:49	Peters4	complete blood count	(none)	basophil differential (BASO; percentage of total WBC) [%] pctBASO 24349 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:53	Peters4	complete blood count	(none)	large unstained cells differential (LUC; percentage of total WBC) [%] pctLUC 24353 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Petkova1:1	Petkova1	immune cell quantification	(none)	white blood cell count (WBC; per volume x 10³) [n/µL] WBC 24201 6mo 12mo 18mo 24mo	inbred	32	both		N=7	2007

Petkova1:6	Petkova1	immune cell quantification	(none)	lymphocyte differential (LYM; percentage of total WBC) [%] LYM 24206 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Petkova1:11	Petkova1	immune cell quantification	(none)	neutrophil differential (NEUT; percentage of total WBC) [%] NEUT 24211 6mo 12mo 18mo 24mo	inbred	32	both		N=7	2007

Petkova1:16	Petkova1	immune cell quantification	(none)	eosinophil differential (EOS; percentage of total WBC) [%] EOS 24216 6mo 12mo 18mo 24mo	inbred	32	both		N=7	2007

Petkova1:21	Petkova1	immune cell quantification	(none)	monocyte differential (MONO; percentage of total WBC) [%] MONO 24221 6mo 12mo 18mo 24mo	inbred	32	both		N=7	2007

Petkova1:25	Petkova1	immune cell quantification	(none)	B cells, as percentage of total lymphocytes [%] B_cells 24225 6mo 12mo 18mo 24mo	inbred	32	both		N=7	2007

Petkova1:29	Petkova1	immune cell quantification	(none)	CD4 T cells, as percentage of total lymphocytes [%] CD4_all 24229 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Petkova1:33	Petkova1	immune cell quantification	(none)	CD4 T cells, naive, as percentage of total CD4 T cells [%] CD4_naive 24233 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Petkova1:37	Petkova1	immune cell quantification	(none)	CD4 T cells, central memory, as percentage of total CD4 T cells [%] CD4_mem_central 24237 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Petkova1:41	Petkova1	immune cell quantification	(none)	CD4 T cells, effector memory, as percentage of total CD4 T cells [%] CD4_mem_effector 24241 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Petkova1:46	Petkova1	immune cell quantification	(none)	CD4 T cells, effector, as percentage of total CD4 T cells [%] CD4_effector 24246 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Petkova1:51	Petkova1	immune cell quantification	(none)	CD8 T cells, as percentage of total lymphocytes [%] CD8_all 24251 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Petkova1:56	Petkova1	immune cell quantification	(none)	CD8 T cells, naive, as percentage of total CD8 T cells [%] CD8_naive 24256 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Petkova1:61	Petkova1	immune cell quantification	(none)	CD8 T cells, central memory, as percentage of total CD8 T cells [%] CD8_mem_central 24261 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Petkova1:66	Petkova1	immune cell quantification	(none)	CD8 T cells, effector memory, as percentage of total CD8 T cells [%] CD8_mem_effector 24266 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Petkova1:71	Petkova1	immune cell quantification	(none)	CD8 T cells, effector, as percentage of total CD8 T cells [%] CD8_effector 24271 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Petkova1:76	Petkova1	immune cell quantification	(none)	natural killer (NK) cells, as percentage of total lymphocytes [%] NK 24276 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

RIKEN-EAD1:16	RIKEN-EAD1	complete blood count	(none)	white blood cell count (WBC; per volume x 10³) [n/µL] WBC 37216	inbred RBRC	45	both	8wks	N=11	2008

RIKEN-EAD2:16	RIKEN-EAD2	complete blood count	(none)	white blood cell count (WBC; per volume x 10³) [n/µL] WBC 37816	wild-derived RBRC	29	both	8wks	N=12	2008

Schughart4:41	Schughart4	complete blood count	influenza A (H3N2) virus	white blood cell count (WBC; per volume x 10³), control group, day 3 [n/µL] WBC_ctrl_d3 58741	inbred w/CC8	8	f	8-12wks	N=5	2016

Schughart4:43	Schughart4	complete blood count	influenza A (H3N2) virus	white blood cell count (WBC; per volume x 10³), treated group [n/µL] WBC_trt 58743 days post-infection: 3 5 8 18 30	inbred w/CC8	8	f	8-12wks	N=6	2016

Schughart4:51	Schughart4	complete blood count	influenza A (H3N2) virus	lymphocyte differential (percent of total WBC), control group, day 3 [%] pctLYM_ctrl_d3 58751	inbred w/CC8	8	f	8-12wks	N=5	2016

Schughart4:53	Schughart4	complete blood count	influenza A (H3N2) virus	lymphocyte differential (LYM; percentage of total WBC), treated group [%] pctLYM_trt 58753 days post-infection: 3 5 8 18 30	inbred w/CC8	8	f	8-12wks	N=6	2016

Schughart4:61	Schughart4	complete blood count	influenza A (H3N2) virus	monocyte differential (percent of total WBC), control group, day 3 [%] pctMONO_ctrl_d3 58761	inbred w/CC8	8	f	8-12wks	N=5	2016

Schughart4:63	Schughart4	complete blood count	influenza A (H3N2) virus	monocyte differential (MONO; percentage of total WBC), treated group [%] pctMONO_trt 58763 days post-infection: 3 5 8 18 30	inbred w/CC8	8	f	8-12wks	N=6	2016

Schughart4:71	Schughart4	complete blood count	influenza A (H3N2) virus	granulocyte differential (percent of total WBC), control group, day 3 [%] pctGRA_ctrl_d3 58771	inbred w/CC8	8	f	8-12wks	N=5	2016

Schughart4:73	Schughart4	complete blood count	influenza A (H3N2) virus	granulocyte differential (GRA; percentage of total WBC), treated group [%] pctGRA_trt 58773 days post-infection: 3 5 8 18 30	inbred w/CC8	8	f	8-12wks	N=6	2016

Svenson3:1	Svenson3	complete blood count	(none)	white blood cell count (WBC; per volume x 10³) [n/µL] WBC 27301	B6.PWD consomic w/par	28	both	7wks	N=8	2006

Svenson3:3	Svenson3	complete blood count	(none)	neutrophil differential (NEUT; percentage of total WBC) [%] pctNEUT 27303	B6.PWD consomic w/par	28	both	7wks	N=8	2006

Svenson3:4	Svenson3	complete blood count	(none)	lymphocyte differential (LYM; percentage of total WBC) [%] pctLYM 27304	B6.PWD consomic w/par	28	both	7wks	N=8	2006

Svenson3:5	Svenson3	complete blood count	(none)	monocyte differential (MONO; percentage of total WBC) [%] pctMONO 27305	B6.PWD consomic w/par	28	both	7wks	N=8	2006

Svenson3:6	Svenson3	complete blood count	(none)	eosinophil differential (EOS; percentage of total WBC) [%] pctEOS 27306	B6.PWD consomic w/par	28	both	7wks	N=8	2006

Svenson3:7	Svenson3	complete blood count	(none)	basophil differential (BASO; percentage of total WBC) [%] pctBASO 27307	B6.PWD consomic w/par	27	both	7wks	N=8	2006

Svenson3:8	Svenson3	complete blood count	(none)	large unstained cell differential (LUC; percentage of total WBC) [%] pctLUC 27308	B6.PWD consomic w/par	28	both	7wks	N=8	2006

Williams1:1	Williams1	immune cell quantification	(none)	CD4 Treg cells (CD25+ CD44^int; as percentage of lymphocytes) [%] Treg 42901	inbred	5	f	8wks	N=3	2012

Williams1:2	Williams1	immune cell quantification	(none)	CD4 Treg cells (CD25+ CD44^int; as percentage of CD4 T cells) [%] Treg_adj 42902	inbred	5	f	8wks	N=3	2012

Williams1:3	Williams1	immune cell quantification	(none)	memory-effector CD4 T cells (CD25^- CD44^hi; as percentage of lymphocytes) [%] memoryT 42903	inbred	5	f	8wks	N=3	2012

Williams1:4	Williams1	immune cell quantification	(none)	memory-effector CD4 T cells (CD25^- CD44^hi; as percentage of CD4 T cells) [%] memoryT_adj 42904	inbred	5	f	8wks	N=3	2012

Williams1:5	Williams1	immune cell quantification	(none)	naive CD4 T cells (CD25^- CD44^lo; as percentage of lymphocytes) [%] naiveT 42905	inbred	5	f	8wks	N=3	2012

Williams1:6	Williams1	immune cell quantification	(none)	naive CD4 T cells (CD25^- CD44^lo; as percentage of CD4 T cells) [%] naiveT_adj 42906	inbred	5	f	8wks	N=3	2012

Wiltshire4:1	Wiltshire4	immune cell quantification	BEZ235	B cells, percent viability [%] Bcells_BEZ 52401 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	34	m	10wks	N=4	2015

Wiltshire4:7	Wiltshire4	immune cell quantification	BEZ235	T cells, percent viability [%] Tcells_BEZ 52407 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	34	m	10wks	N=4	2015

Wiltshire4:13	Wiltshire4	immune cell quantification	BEZ235	monocytes, percent viability [%] monocytes_BEZ 52413 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	34	m	10wks	N=4	2015

Wiltshire4:21	Wiltshire4	immune cell quantification	doxorubicin	B cells, percent viability [%] Bcells_Dox 52421 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	35	m	10wks	N=4	2015

Wiltshire4:27	Wiltshire4	immune cell quantification	doxorubicin	T cells, percent viability [%] Tcells_Dox 52427 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	35	m	10wks	N=4	2015

Wiltshire4:33	Wiltshire4	immune cell quantification	doxorubicin	monocytes, percent viability [%] monocytes_Dox 52433 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	35	m	10wks	N=4	2015

Wiltshire4:41	Wiltshire4	immune cell quantification	idarubicin	B cells, percent viability [%] Bcells_Ida 52441 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	35	m	10wks	N=4	2015

Wiltshire4:47	Wiltshire4	immune cell quantification	idarubicin	T cells, percent viability [%] Tcells_Ida 52447 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	35	m	10wks	N=4	2015

Wiltshire4:53	Wiltshire4	immune cell quantification	idarubicin	monocytes, percent viability [%] monocytes_Ida 52453 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	35	m	10wks	N=4	2015

Wiltshire4:61	Wiltshire4	immune cell quantification	selumetinib	B cells, percent viability [%] Bcells_Sel 52461 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	34	m	10wks	N=4	2015

Wiltshire4:67	Wiltshire4	immune cell quantification	selumetinib	T cells, percent viability [%] Tcells_Sel 52467 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	34	m	10wks	N=4	2015

Wiltshire4:73	Wiltshire4	immune cell quantification	selumetinib	monocytes, percent viability [%] monocytes_Sel 52473 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	34	m	10wks	N=4	2015